Dr Andrew Roddam is an accomplished life science executive and internationally renowned epidemiologist with over 20 years of experience across both academia and the pharmaceutical industry, principally focused on the application and use of real-world data and epidemiological methods to advance the understanding of human disease. He has a strong interest in health informatics and is an experienced board member within the UK and internationally who regularly participates at international meetings and conferences as a keynote speaker. Andrew previously served as the CEO of Our Future Health, the UK's largest health research programme (in partnership with NHS) and is currently the Chief Strategy Officer of EveryONE Medicines, an organization committed to developing individualized precision therapeutics. Andrew has served as a Management Board Director to SNOMED International since October 2020 and was appointed Chair in October 2024.

Bersabel Ephrem brings to the Management Board 32 years of experience in the areas of leadership, governance and public health policy and program management and has worked in several organizations within the Canadian Federal Government. Most recently, she served as the Director General of Centre of Communicable Diseases and Infection Control within the Public Health Agency of Canada. Prior to that, Bersabel served as the Senior Advisor to the Director General of the World Health Organization on management reform, where she provided leadership and oversight in the development of policies and institutionalized key governance initiatives. Bersabel has also served as Director General at the International Affairs Division of Health Canada. In this role, Bersabel led the Canadian delegation on several groundbreaking negotiations in WHO and the Pan American Health Organization. Her international experience has provided her with unique insights on the challenges global healthcare-focused organizations must navigate and on successful strategies to advance on their goals. Bersabel has served as a Management Board Director to SNOMED International since February 2023.

Dr. Juana L. Flores Candia is an established executive at Board Level with more than 20 years of experience in Healthcare. She built innovation pipelines, achieved successful business turnarounds, and drove digital transformations while holding significant leadership roles in multinational settings at Roche, GSK, and Novartis. Moved by her passion for translating cutting-edge technologies into healthcare products and solutions to improve healthcare outcomes, she lived and worked in seven countries and three continents. Currently, she is the Chief Innovation Officer at AtG Therapeutics and serves on several Boards of companies committed to bringing AI solutions to healthcare, developing novel therapies, and improving clinical trial management. Juana was appointed as a Management Board Director to SNOMED International in October 2024.

Anne-Marie Grey brings more than 30 years of humanitarian fundraising and marketing experience, both in the United States and internationally to SNOMED International. The recent Executive Director and CEO for USA for UNHCR, Anne-Marie is the Principal Director at New York-based Grey-O’Keefe Consulting LLC, a training, strategy, and marketing agency that brings causes and corporations together to positively impact society and business. She brings to the Board her unique and extensive leadership skills in both the not-for-profit and private sectors. Anne-Marie has mentored and advised non-profit leaders on resource mobilization, leadership and strategy at organizations such as the Forbes Nonprofit Council, an invitation-only, fee-based organization for senior-level executives in successful nonprofit organizations; USA for UNHCR; UNHCR; Save the Children; and UNICEF. In addition to an educational background in art history, literature, finance and non-profit management, Anne-Marie has obtained DiSC and Five Behaviors partner certification, and is a Certified Professional Co-Active Coach and International Coaching Federation credential trained coach, facilitator, author, and international speaker. Anne-Marie has served as a Management Board Director to SNOMED International since February 2023.

Christian Hein is an Executive Advisor and Board Director in health tech and AI with 20 years of global pharma leadership experience at Novartis, Amgen, and Actelion. Formerly VP of Digital Transformation and Innovation Execution at Novartis, he has a background in strategy consulting and life science venture capital. Christian advises and serves on boards of leading life science organizations and innovative AI health tech startups, including Quant Health, a pioneer in AI for clinical development. Christian was appointed to the Management Board of SNOMED International in October 2024.

Bettina McMahon has held senior executive roles in the Australian public health sector over the past 15 years. She is currently the Chief Executive Officer of Healthdirect Australia, which is Australia’s national provider of virtual triage, advice, and after-hours virtual care. Bettina has considerable experience in digital transformation in the health sector, and across the Australian public sector prior to that in areas of anti-money laundering, aviation security, and environmental protection. Before joining Healthdirect, Bettina was the Interim Chief Executive Officer at the Australian Digital Health Agency, where she had also held executive roles since 2009. From 2020-2024, Bettina was the Board Chair of the Australasian Institute of Digital Health; Australia's peak body for digital health representing health informaticians, digital health leaders, and practitioners. Bettina has postgraduate qualifications in public policy, applied finance, and business and technology. Bettina was appointed to the Management Board of SNOMED International in October 2024.